A Potential Novel Marker for Liver Fibrosis in Nonalcoholic Steatohepatitis: the Soluble Secreted Form of the Human Asialoglycoprotein Receptor Non-interventional Study.
1. Signed informed consent.
2. Patient candidate to bariatric surgery.
1. Liver biopsy during the last 12 months.
2. The surgeon consider liver biopsy as a special dander in a specific patient.
Type of Study:
Observational Model: Case Control, Time Perspective: Cross-Sectional
Osamah Hussein, MD
Ziv Medical Center
Israel: Ethics Commission
- Liver Fibrosis
- human asialoglycoprotein receptor (ASGPR)
- bariatric surgery
- Liver Cirrhosis